Purpose: To assess the toxicity effects of the secondary metabolites extract from C. nuda using in vitro toxicity testing methods.
Methods: The cytotoxic effect of the secondary metabolites extract was investigated with cytotoxicity assay using both animal and human cell lines. The acute oral LD50 values were also estimated based on an established prediction model. Besides, genotoxic effects of this secondary metabolites extract were evaluated with two standard in vitro genotoxicity assays: bacteria reverse mutation assay and cytokinesis-blocked micronucleus cytome assay. Moreover, the potential influences of heat treatment to the secondary metabolites extract toxicity were also investigated.
Results: The estimated acute oral LD50 values of this secondary metabolites extract are higher than the threshold value of 2,000 mg/kg body weight, which can be classified as non-toxic according to the state-of-the-art recommendation. Also, there are no significant differences (P<0.05) between this secondary metabolites extract and controls for all of the genotoxic biomarkers examined in both bacteria and human hepatoma cells. Results from this study indicate that the secondary metabolites extract from C. nuda is not genotoxic and might also be properly classified as non-acute-oral-toxic.
Significance: Results from this study can help to prove the safety of the secondary metabolites extract from C. nuda to be added into foods as a novel natural antimicrobial.